Risk factors for acute rejection in living donor liver transplantation

Clin Transplant. 2003 Aug;17(4):347-52. doi: 10.1034/j.1399-0012.2003.00057.x.

Abstract

The influence of human leukocyte antigen (HLA) compatibility and lymphocytotoxic crossmatch on acute rejection in living donor liver transplantation (LDLT) has not been well examined. We analyzed 100 consecutive adult LDLT cases. The patient and graft survival rates and post-operative complications were assessed. The relation between the incidence of acute rejection and some clinical factors including HLA and lymphocytotoxic matching was also examined. Patients with HLA DR zero mismatching (p = 0.02) or negative T-lymphocytotoxic crossmatch (p = 0.04) had a significantly lower chance of rejection within 6 wk after LDLT. However the results had no influence on the patient survival. Our results demonstrate that in LDLT, a graft from an HLA-DR zero mismatching or negative T-lymphocytotoxic crossmatch might be advantageous because of the decreased probability of early acute rejection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adult
  • Aged
  • Child
  • Female
  • Graft Rejection / immunology*
  • Graft Survival
  • HLA-DR Antigens / immunology
  • Histocompatibility Testing
  • Humans
  • Liver Transplantation / immunology*
  • Living Donors*
  • Male
  • Middle Aged
  • Postoperative Care
  • Risk Factors
  • T-Lymphocytes, Cytotoxic / immunology

Substances

  • HLA-DR Antigens